ASHLEY ALEXANDER: Open Payments
NPI 1891033213 · FRANKLIN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 23 payments from 9 companies in 2025. Trend: 2023 $266 · 2024 $333 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $94 |
| Ardelyx, Inc. | 2 | $45 |
| Celltrion USA Inc. | 1 | $40 |
| Aimmune Therapeutics, Inc. | 1 | $37 |
| Alnylam Pharmaceuticals Inc. | 1 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Intercept Pharmaceuticals, Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $20 |
Products named: SKYRIZI, ENTYVIO, LINZESS, IBSRELA, VEGZELMA, VOWST, GIVLAARI, DUPIXENT.
Industry payments across VA — which companies pay providers there.
